David Roblin, CEO, Relation Therapeutics In 2012, Jack Scannell, a pharma industry expert, coined the term “EROOM’s law.” This was a vivid way to contrast the declining rate of productivity in drug discovery with the rapid acceleration in computing power that became known after the 1960s as Moore’s law. Eroom’s law stated that the number of new drugs approved per billion US dollars spent on R&D has halved roughly every 9 years since 1950, an 80-fold decrease in inflation-adjusted terms.
David Roblin
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with David
Contact David, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack